Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
glucosamine
- Development stage
- Unknown
- Lead developer
- Pharma Nord
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Glucosamine is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, specifically glycosaminoglycans and proteoglycans found in articular cartilage. As a therapeutic agent, particularly in the form of glucosamine sulfate (e.g., Glukosamin Pharma Nord), it is classified as a symptomatic slow-acting agent for osteoarthritis (SYSADOA). It is used to alleviate symptoms of mild to moderate osteoarthritis, including pain relief and improvement of joint mobility. The drug is reported to possess anti-inflammatory, antioxidative, and anti-catabolic properties, which help maintain joint tissue integrity. It has been specifically evaluated in Phase 4 clinical trials for the treatment of temporomandibular joint (TMJ) osteoarthritis at an oral dose of 1,200 mg per day.
- Brand names
- Glukosamin Pharma Nord
- Other names
- Glukosaminglucosamine sulfate
Beyond the preview
Go deeper on glucosamine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on glucosamine.